ANTIBIOTIC RESISTANCE OF MICROORGANISMS ISOLATED FROM PATIENTS OF SURGICAL HOSPITAL | Zendy

Крюкова | Zendy; Natalya Kryukova | Zendy; Анганова | Zendy; Е. В. Анганова | Zendy; Савилов | Zendy; Е. Д. Савилов | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

ANTIBIOTIC RESISTANCE OF MICROORGANISMS ISOLATED FROM PATIENTS OF SURGICAL HOSPITAL

Author(s) -

Крюкова,

Natalya Kryukova,

Анганова,

Е. В. Анганова,

Савилов,

Е. Д. Савилов

Publication year - 2016

Publication title -

бюллетень восточно-сибирского научного центра сибирского отделения российской академии медицинских наук

Language(s) - English

Resource type - Journals

ISSN - 1811-0649

DOI - 10.12737/23821

Subject(s) - cefotaxime , sulbactam , microbiology and biotechnology , ceftazidime , pseudomonas aeruginosa , antibiotic resistance , acinetobacter , antibiotics , antimicrobial , medicine , biology , imipenem , bacteria , genetics

Infections received in the course of healthcare delivery continue to be an urgent medical and socio-economical issue. This problem is exacerbated by formation and wide spread of strains polyresistant to current germicides.The article presents the results of a study of antibiotic resistance of microorganisms isolated from patients of surgical hospitalof Neryungri Central Regional Hospital. Microorganisms were resistant to various antimicrobial drugs. E.coli were resistant to ampicillinum, ampicillinum/sulbactam and ceftriaxonum; Klebsiellaspp. – to ampisiillinum, chlo-ramphenicolum and cefotaxime; Pseudomonas aeruginosa – to ciprofloxacinum and gentamicinum, Acinetobacterspp. – gentamicinum, ceftazidime and ceftriaxonum; Staphylococcus – to penicillinum. Escherichia coli and Klebsiella spp. produced extended spectrum beta-lactamases (ESBL). Among E.coli, Pseudomonas aeruginosa and Acinetobacter spp. were identified strains resistant to carbapenems. MRSA and MRSE were identified.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research